Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
50.2M
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
45.4M
-
Shares change
-
-82.1K
-
Total reported value, excl. options
-
$1.34B
-
Value change
-
-$4.7M
-
Put/Call ratio
-
0.67
-
Number of buys
-
44
-
Number of sells
-
-70
-
Price
-
$29.50
Significant Holders of Immunocore Holdings plc - ADR (IMCR) as of Q4 2024
151 filings reported holding IMCR - Immunocore Holdings plc - ADR as of Q4 2024.
Immunocore Holdings plc - ADR (IMCR) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45.4M shares
of 50.2M outstanding shares and own 90.38% of the company stock.
Largest 10 shareholders include T. Rowe Price Investment Management, Inc. (6.7M shares), WELLINGTON MANAGEMENT GROUP LLP (6.62M shares), RTW INVESTMENTS, LP (4.87M shares), FMR LLC (4.82M shares), PRIMECAP MANAGEMENT CO/CA/ (2.67M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.19M shares), TANG CAPITAL MANAGEMENT LLC (1.56M shares), BAKER BROS. ADVISORS LP (1.52M shares), GENERAL ATLANTIC, L.P. (1.26M shares), and Kynam Capital Management, LP (1.23M shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.